Related to this topic: Patient+ | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Epidermal Naevus

This is thought to be a variant form of sebaceous naevus (naevus sebaceous) and is a hamartomatous tumour characterised by hyperplasia of the epidermis and/or its associated components. They may present in a variety of forms – Becker's naevus, verrucous epidermal naevus, inflammatory linear verrucous epidermal naevus, naevus comedonicus, eccrine naevus, apocrine naevus and white sponge naevus. They are classified according to clinical morphology, site and extent of involvement, and the predominating epidermal structure within the individual lesion.1

Their most common forms are probably the sebaceous naevus affecting the scalp, and the verrucous epidermal naevus which has the appearance of verrucous papules that coalesce to form well-demarcated papillomata, ranging in colour from that of the surrounding skin to much more deeply pigmented. They may be congenital lesions or develop during the early years of life. They tend to grow during childhood and then stabilise during the teenage years.1 They may be localised to a small area or occur in more diffuse forms. They are often arranged in a linear fashion along skin tension lines or the lines of Blashcko (purported lines of epidermal growth derived from clonal tissue patterns thought to be formed in embryo).2 If there are extensive epidermal naevi then they can be associated with extra-dermal abnormalities as part of the epidermal naevus syndrome.

They have the potential to have benign appendigeal tumours arise within them (often syringocystadenoma papilliferum), or to transform into malignant tumours such as basal cell carcinoma or squamous cell carcinoma. The lifetime risk of malignant transformation in sebaceous naevi is quoted at 5–22%,3 but more recent prospective analyses suggest this figure may be significantly lower.4 Verrucous epidermal naevi seem to have a much lower chance of forming tumours.1 Malignant transformation of the lesion is rare before adolescence/adulthood.

Visual Appearance

A pigmented, linear example of an epidermal naevus

EPIDERMAL NAEVUS -LINEAR (DIS37.jpg)

Epidemiology

Estimated prevalence in newborns for sebaceous naevus is 0.3%. Epidermal naevus probably has a similar or lower prevalence.4

Presentation
  • The lesions are usually noted at birth or shortly thereafter.
  • They are often pigmented but can be the same as surrounding skin.
  • They are often unilateral, linear and tend to follow Blaschko's lines.2
  • May grow and become wart-like during childhood and tend to stabilise during adolescence (in contrast to sebaceous naevi that tend to become hyperplastic in response to sex hormones during adolescence).
Differential Diagnosis
  • Sebaceous naevus
  • Nevus syringocystadenomatosus papilliferus
  • Juvenile xanthogranulomata
  • Solitary mastocytoma
  • Multiple melanocytic naevi.
Associated Diseases

Epidermal naevus syndrome (Jadassohn naevus phakomatosis). This is the presence of multiple or large epidermal naevi associated with disorders affecting the central nervous system, bones and the eye. There are multiple variant syndromes.5 Problems that may arise include:

Investigations
  • None are required if the diagnosis is certain and the lesion has not changed appreciably.
  • If there is doubt as to the nature of the lesion or it has recently developed changes that may signify the presence of benign or malignant tumours, then biopsy should be carried out.
  • If there are extensive epidermal naevi then referral/investigations such as neuroimaging, to detect the presence of an epidermal naevus syndrome, should be considered.
Management
  • There is no treatment required as such, other than reassurance that they are, on the whole, a benign problem.
  • If there is poor cosmetic appearance then consider dermatological/plastic surgical referral for advice on surgical excision or laser ablation.
  • If the naevus is extremely warty or chronically inflamed (as some forms are) then topical immunomodulatory agents such as calcipotriol, tacrolimus and fluocinonide may be helpful.6
Complications
  • Poor cosmetic appearance
  • Inflammation of the lesion in certain forms (inflammatory linear verrucous epidermal naevus)
  • Benign or malignant tumours arising within the lesion.
Prognosis
  • Very good
  • Low risk of benign or malignant tumours arising from the lesion.


Document References
  1. Dosik J, Epidermal Nevus, Dermatology Online Journal 7(1):14, 2001.; Good, concise clinical overview with images.
  2. Whonamedit.com, Blaschko's Lines.; Biographical and clinical summary.
  3. Dunkin CS, Abouzeid M, Sarangapani K; Malignant transformation in congenital sebaceous naevi in childhood. J R Coll Surg Edinb. 2001 Oct;46(5):303-6. [abstract]
  4. Al Hammadi A, Lebwohl M, eMedicine, Nevus Sebaceous, 2006.; Good images.
  5. Sugarman JL; Epidermal nevus syndromes.; Semin Cutan Med Surg. 2004 Jun;23(2):145-57. [abstract]
  6. Mutasim DF; Successful treatment of inflammatory linear verrucous epidermal nevus with tacrolimus and fluocinonide. J Cutan Med Surg. 2006 Jan-Feb;10(1):45-7. [abstract]

Internet and Further Reading Acknowledgements EMIS is grateful to Dr Sean Kavanagh for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 538
Document Version: 20
DocRef: bgp26031
Last Updated: 20 Mar 2007
Review Date: 19 Mar 2009




















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page